CARsgen Therapeutics saw the highest growth of 199% in patent filings in November and 49% in grants in December in Q4 2023. Compared to Q3 2023, Q4 2023 saw no growth in patent filings and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of CARsgen Therapeutics’s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

CARsgen Therapeutics has been focused on protecting inventions in China(CN) with four publications in Q4 2023

The China(CN) Patent Office dominates the patent filings and grants with nearly 67% filings and 67% grants. The China(CN), World Intellectual Property Organization(WIPO), and Israel(IL) patent Office are among the top ten patent offices where CARsgen Therapeutics is filings its patents. Among the top granted patent authorities, CARsgen Therapeutics has 67% of its grants in China(CN) and 33% in Israel(IL).

Patents related to cell & gene therapy and immuno-oncology lead CARsgen Therapeutics's portfolio

CARsgen Therapeutics has the highest number of patents in cell & gene therapy followed by, immuno-oncology. For cell & gene therapy, nearly 50% of patents were filed and no patents were granted in Q4 2023.

For comprehensive analysis of CARsgen Therapeutics's filings and grants, buy the databook here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.